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The most interesting point about immunization experiments with these proteinaceous materials is that they induce skin-sensitizing antibodies, as well as other circulating antibodies, in both guinea-pigs and baboons. It is this which gives us some confidence that the impurity is important in induction of hypersensitivity in man, particularly since the antibody induced bears a close relationship to the amount of this impurity present. We are at the moment investigating whether these antibodies can be transferred to another baboon.
There is no doubt that this impurity is also important in that it can induce a response with human reagin. This we have done in baboons but the most valuable results in this area were obtained for us by Dr Stewart using human skin tests (Stewart 1967) . All the evidence suggests to us that this proteinaceous impurity plays an important part when penicilloyl specificity is involved which, on the evidence from penicilloyl polylysine skin testing (Parker et al. 1962 ), seems to be in about 75 % of allergic patients. 'Polymer': We come finally to the problem of 'polymer.' By this we do not mean polymer in the chemical sense though the evidence is that the substances involved are such polymers. We use the expression to describe a phenomenon which became apparent after we had succeeded in purifying both 6-APA and benzylpenicillin with respect to the proteinaceous impurity. The picture is relatively clear with 6-APA. A solution of pure 6-APA rapidly regains the ability to elicit a response with rabbit antipenicilloyl serum in guinea-pigs. The same occurs slowly in the dry solid and we have shown that something similar occurs very slowly in benzylpenicillin after months of storage, though here the penicillin itself is a good inhibitor and must first be separated to allow the 'polymer' to be detected by immunological methods.
Most of our work has necessarily been carried out with the more readily available 'polymer' from 6-APA. Its structure is not yet worked out though it seems to be a linear chain somewhat like the material reported by Grant et al. (1962) . It does not seem to conjugate to protein. We have been unable to stimulate antibody formation or delayed hypersensitivity with this polymer. This is not unexpected since it seems to be a homopolymer. Since it readily reacts in many antibody systems we must conclude that it could react with reaginic antibody of the penicilloyl specificity and could be important in causing an allergic response. The discovery of the penicilloyl-protein contaminants in 6-APA and penicillins in 1962 owes everything to serendipity and scepticism: serendipity because they produced passive cutaneous anaphylaxis in the guinea-pig when nobody suspected their existence; scepticism because, being an immunological classicist, I refused to believe that a simple hapten like 6-APA could evoke an immediate PCA reaction in guinea-pigs sensitized with rabbit anti-penicilloyl serum.
My first thought was of the notorious property of 6-APA and penicillins to polymerize, but dialysis of concentrated 6-APA solutions dropped the penicilloyl-protein into my lap instead. As a preliminary look at some 6-APA polymers had been unrewarding, I gave top priority to the hunt for, and isolation, purification and characterization of these hitherto unsuspected penicilloylproteins from 6-APA and the penicillins themselves.
We found them everywhere and determined that they contained at least 12 amino acids plus the penicilloyl group, the latter inducing penicilloyl-specific antibodies and sensitization in experimental animals (Feinberg 1967a (Feinberg , b, 1968a . In the case of 6-APA, the protein seemed to be largely of Esch. coli origin, the latter being the source of the amidase used to degrade penicillin G to 6-APA. The proteins could be removed by dialysis, gel filtration, adsorption and other standard techniques.
The structure of the cephalosporins (Loder et al. 1961) made it apparent to me that similar proteins might well be found as contaminants of these antibiotics. Certainly, cephalosporin N was really a penicillinand it seemed to me that the P-lactam ring of the true cephalosporins could possess the full potential of the P-lactam structure of the penicillins for attachment to proteins (Feinberg 1968a) . Subsequently, Stewart (1967) actually reported immunogenic macromolecular complexes derived from 7-aminocephalosporanic acid.
All of this augured well for realization of the decades-long dream of producing nonsensitizing penicillins. But the realization could only come about if the various penicillin molecules were not immunogenic in themselves. One had to reckon with the fact that clinical use of the antibiotics dictated conditions which were absolutely ideal for utilizing any protein-coupling potential of the antibiotic molecule: i.e. elevated concentrations of the antibiotic in the blood for protracted periods of time. Such covalent penicillin-plasma protein compounds, if formed, would undoubtedly be highly immunogenic.
This question needed resolving and in 1963 I initiated a study on the innate immunogenicity of several penicillins (Feinberg 1968b) . Briefly, what I found was that whereas purified penicillin G and methicillin were very immunogenic in themselves, propicillin and phenethicillin were virtually nonimmunogenicat least in the rabbit. As I left this line of work prematurely, I was only able to observe that results obtained with penicillin V were equivocal, but its immunogenic potential seemed to lie intermediate between the two immunogenic and the two hypoimmunogenic penicillins.
When one looks at the structures of these penicillins, one is struck by certain relationships (Fig 1) . I would like to speculate that substitution of a phenoxy for the phenyl group of the penicillin G molecule lowers its immunogenicity; and that lengthening the methyl group of penicillin V to ethyl and then to propyl further decreases the immunogenic potential of the penicillin molecule. This may be due to steric interference of the interpolated group with the ability of the penicillin to form the highly protein-binding penicillenic acidwhich I showedor to other mechanisms, possibly including enzyme action.
Developments along these lines may, it is hoped, make it possible in future to tailor-make hypoallergenic penicillinsand possibly cephalosporins also. If such can be made, we have the knowledge to keep them free of macromolecular, allergenic contaminants.
